IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q3 2022 Holdings

Filed 2022-11-14 | 2 holdings | $112.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$111.8M2,346,93499.9%
Lyell Immunopharma IncCOM55083R104$147.8K20,162,3320.1%